What does CUSIP M47238106 represent in this 13F holders report?

CUSIP M47238106 is the security identifier for GLMD - GALMED PHARMACEUTICALS LTD - SHS used to aggregate holder disclosures.

How many institutions held GLMD - GALMED PHARMACEUTICALS LTD - SHS in Q1 2018?

19 institutional investors reported GLMD - GALMED PHARMACEUTICALS LTD - SHS for Q1 2018. Use the holders table for investor-level position and value details.

GALMED PHARMACEUTICALS LTD - SHS (GLMD)

CUSIP: M47238106

Q1 2018 13F Holders as of 31 Mar 2018

Security type / class: Equity / SHS
Total 13F shares: 2,654,611
Total 13F value: $14,778,000
Share change: -74,691
SEC-reported price per share: $5.57
Number of holders: 19
Value change: -$1,301,577
Number of buys: 11
Number of sells: 7

Security key

M47238106

Report period

Q1 2018

Institutions

Top holders

GLMD full security history Ownership snapshot Full 13F holder table Galmed Pharmaceuticals Ltd. SEC filings Galmed Pharmaceuticals Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of GLMD - GALMED PHARMACEUTICALS LTD - SHS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

683 Capital Management, LLC

Disclosed value leader

683 Capital Management, LLC

Comparable rows

0/15

Latest evidence

31 Dec 2017

13F Highest disclosed value: $5,941,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

683 Capital Management, LLC has the largest disclosed position value at $5.94M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 683 Capital Management, LLC's linked filing trail.

Disclosed position value Top 5

683 Capital Management, LLC $5.94M

MEITAV INVESTMENT HOUSE LTD $4.36M

Nantahala Capital Management, LLC $3.66M

Park West Asset Management LLC $2.68M

SPHERA FUNDS MANAGEMENT LTD. $2.16M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
683 Capital Management, LLC	13F Company 13F	— denominator unverified	$5,941,000 649,295 shares	—	31 Dec 2017
MEITAV INVESTMENT HOUSE LTD	13F Company 13F	— denominator unverified	$4,357,000 476,190 shares	—	31 Dec 2017
Nantahala Capital Management, LLC	13F Company 13F	— denominator unverified	$3,660,000 400,000 shares	—	31 Dec 2017
Park West Asset Management LLC	13F Company 13F	— denominator unverified	$2,679,000 292,847 shares	—	31 Dec 2017
SPHERA FUNDS MANAGEMENT LTD.	13F Company 13F	— denominator unverified	$2,164,000 238,095 shares	—	31 Dec 2017
IBEX INVESTORS LLC	13F Company 13F	— denominator unverified	$2,077,000 227,000 shares	—	31 Dec 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,654,611

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q1 2018 value	Q1 2018 value	Value change	Value Chg %